Plasma amyloid β (Aβ) protein 1-42 (Aβ42) levels are increased in down syndrome (DS) but not in Alzheimer disease (AD)

被引：0
|
作者：
Mehta, PD
Dalton, AJ
Mehta, SP
Kim, KS
Wisniewski, HM
Aisen, PS
机构：
来源：
NEUROLOGY | 1998年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P04109
引用
下载
收藏
页码：A233 / A233
页数：1
相关论文
共 50 条
  • [21] Amyloid beta-protein 42, Alzheimer's disease, and Down's syndrome
    不详
    NEUROSCIENTIST, 1996, 2 (04): : 201 - 201
  • [22] Role of amyloid β1-42 and neuroimaging biomarkers in Alzheimer's disease
    Lista, Simone
    Emanuele, Enzo
    BIOMARKERS IN MEDICINE, 2011, 5 (04) : 411 - 413
  • [23] Amyloid β protein 1-38 (Aβ38), Aβ40 and Aβ42 levels in matched CSF and Alzheimer disease (AD)
    Mehta, P. D.
    Pirttila, T.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 245 - 245
  • [24] Plasma levels of amyloid beta protein species (A beta 1-40 and A beta 1-42(43)) are elevated in Down's syndrome.
    Tamaoka, A
    Tokuda, T
    Fukushima, T
    Ikeda, S
    Sekijima, Y
    Shoji, S
    Yanagisawa, N
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 : S39 - S39
  • [25] Decreased serum amyloid β1-42 autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid β1-42 peptide
    Brettschneider, S
    Morgenthaler, NG
    Teipel, SJ
    Fischer-Schulz, C
    Bürger, K
    Dodel, R
    Du, YS
    Möller, HJ
    Bergmann, A
    Hampel, H
    BIOLOGICAL PSYCHIATRY, 2005, 57 (07) : 813 - 816
  • [26] In vitro and in vivo protein oxidation induced by Alzheimer's disease amyloid β-peptide (1-42)
    Butterfield, DA
    Yatin, SM
    Link, CD
    OXIDATIVE/ENERGY METABOLISM IN NEURODEGENERATIVE DISORDERS, 1999, 893 : 265 - 268
  • [27] Memory decline correlates with increased plasma cytokines in amyloid-beta (1-42) rat model of Alzheimer's disease
    Shallie, Oluwadamilola F.
    Dalle, Ernest
    Mabandla, Musa V.
    NEUROBIOLOGY OF LEARNING AND MEMORY, 2020, 169
  • [28] Plasma levels of amyloid beta proteins A beta 1-40 and A beta 1-42(43) are elevated in Down's syndrome
    Tokuda, T
    Fukushima, T
    Ikeda, S
    Sekijima, Y
    Shoji, S
    Yanagisawa, N
    Tamaoka, A
    ANNALS OF NEUROLOGY, 1997, 41 (02) : 271 - 273
  • [29] Highly increased CSF tau protein and decreased β-amyloid (1-42) in sporadic CJD:: a discrimination from Alzheimer's disease?
    Kapaki, E
    Kilidireas, K
    Paraskevas, GP
    Michalopoulou, M
    Patsouris, E
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 71 (03): : 401 - 403
  • [30] Cerebrospinal fluid amyloid β1-42 levels in the mild cognitive impairment stage of Alzheimer's disease
    Maruyama, M
    Arai, H
    Sugita, M
    Tanji, H
    Higuchi, M
    Okamura, N
    Matsui, T
    Higuchi, S
    Matsushita, S
    Yoshida, H
    Sasaki, H
    EXPERIMENTAL NEUROLOGY, 2001, 172 (02) : 433 - 436
12345